TOR THERAPEUTICS Trademark

Trademark Overview

On Friday, January 7, 2022, a trademark application was filed for TOR THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TOR THERAPEUTICS trademark a serial number of 97208554. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 19, 2024. This trademark is owned by TOR Therapeutics, Inc.. The TOR THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and products for the prevention and treatment of neoplastic, autoimmune, inflammatory immunological, degenerative, aging, vascular and metabolic diseases, disorders and conditions
tor therapeutics

General Information

Serial Number97208554
Word MarkTOR THERAPEUTICS
Filing DateFriday, January 7, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and products for the prevention and treatment of neoplastic, autoimmune, inflammatory immunological, degenerative, aging, vascular and metabolic diseases, disorders and conditions
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTOR Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMeadowbrook, PA 19046
Party NameTOR Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMeadowbrook, PA 19046

Trademark Events

Event DateEvent Description
Tuesday, February 20, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 19, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, September 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 28, 2023SOU EXTENSION 1 GRANTED
Monday, July 17, 2023SOU EXTENSION 1 FILED
Tuesday, September 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 28, 2023NOTICE OF REVIVAL - E-MAILED
Monday, August 28, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, August 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 28, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, August 28, 2023NOTICE OF REVIVAL - E-MAILED
Monday, August 28, 2023PETITION TO REVIVE-GRANTED
Monday, August 28, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, August 21, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 21, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 17, 2022EXAMINER'S AMENDMENT ENTERED
Monday, October 17, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 17, 2022EXAMINERS AMENDMENT E-MAILED
Monday, October 17, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, October 13, 2022ASSIGNED TO EXAMINER
Friday, January 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 11, 2022NEW APPLICATION ENTERED

Related Keywords

therapeutics vascular aging degenerative metabolic diseases conditions disorders immunological inflammatory products